[SYRS] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
10-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -154.12%
YoY- 36.87%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 0 2,954 5,467 4,827 2,379 454 370 -
PBT -3,708 -23,789 -25,146 -14,228 -17,226 -16,461 -14,463 -20.27%
Tax 291 -8,865 -1,507 967 0 0 0 -
NP -3,708 -14,924 -23,639 -14,228 -17,226 -16,461 -14,463 -20.27%
Tax Rate - - - - - - - -
Total Cost 3,708 17,878 29,106 19,055 19,605 16,915 14,833 -20.61%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 0.00 -505.21 -432.39 -294.76 -724.09 -3,625.77 -3,908.92 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.10 -0.54 -3.75 -2.32 -3.92 -4.87 -4.77 -47.45%
EPS Diluted -0.10 -0.54 -3.75 -2.32 -3.92 -4.87 -4.77 -47.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.